Bank of Nova Scotia
TNDM icon

Bank of Nova Scotia’s Tandem Diabetes Care TNDM Stock Holding History

Bank of Nova Scotia’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-65,497
Closed -$7.62M – 1265
2022
Q1 		$7.62M Buy
+65,497
New +$7.65M 0.01% 510
2021
Q4 		– Sell
-9,543
Closed -$1.14M – 1297
2021
Q3 		$1.14M Sell
9,543
-160,457
-94% -$17.7M ﹤0.01% 925
2021
Q2 		$16.6M Buy
+170,000
New +$15.2M 0.03% 357
2021
Q1 		– Sell
-2,372
Closed -$227K – 1103
2020
Q4 		$227K Sell
2,372
-52,708
-96% -$5.43M ﹤0.01% 955
2020
Q3 		$6.25M Buy
+55,080
New +$5.79M 0.02% 429

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Bank of Nova Scotia's TNDM Position: Q2 2022 in Review

Bank of Nova Scotia sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 65,497 shares — an estimated $7.62M sold.

Bank of Nova Scotia first reported a position in TNDM in Q3 2020 and held it in 5 quarters. The position peaked at $16.6M in Q2 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Bank of Nova Scotia reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 65,497 Tandem Diabetes Care shares in Q2 2022, an estimated $7.62M.
  • Bank of Nova Scotia first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 5 quarters.
  • Bank of Nova Scotia's Tandem Diabetes Care position peaked at $16.6M in Q2 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Bank of Nova Scotia's 13F filing for Q2 2022, filed 5 Aug 2022.